Process economics of industrial monoclonal antibody manufacture.
暂无分享,去创建一个
[1] David F. Ollis,et al. Biochemical Engineering Fundamentals , 1976 .
[2] Peter L. Douglas,et al. Computer simulation for large scale bioprocess design , 2001 .
[3] S Karri,et al. A Tool for Modeling Strategic Decisions in Cell Culture Manufacturing , 2000, Biotechnology progress.
[4] Peter Latham,et al. When “Make or Buy“ Means “Make or Break” , 1994, Bio/Technology.
[5] Carl-Gustaf Rosen,et al. Process Economics of Animal Cell and Bacterial Fermentations: A Case Study Analysis of Tissue Plasminogen Activator , 1993, Bio/Technology.
[6] Mic N. Hamers,et al. Multiuse Biopharmaceutical Manufacturing , 1993, Bio/Technology.
[7] Christopher D. Martin,et al. Financial Evaluation of Environmental Investments , 1996 .
[8] Keith L Carson. Flexibility—the guiding principle for antibody manufacturing , 2005, Nature Biotechnology.
[9] P Dunnill,et al. Prediction of the pilot-scale recovery of a recombinant yeast enzyme using integrated models. , 2001, Biotechnology and bioengineering.
[10] Ferda Mavituna,et al. Biochemical engineering and biotechnology handbook , 1982 .
[11] T Shanklin,et al. Selection of bioprocess simulation software for industrial applications. , 2001, Biotechnology and bioengineering.
[12] G. Allard,et al. Production of a diagnostic monoclonal antibody in perennial alfalfa plants. , 1999, Biotechnology and bioengineering.
[13] Roger G. Harrison,et al. Bioseparations Science and Engineering , 2002 .
[14] Jerry Banks,et al. Handbook of simulation - principles, methodology, advances, applications, and practice , 1998, A Wiley-Interscience publication.
[15] K. Thiel,et al. Biomanufacturing, from bust to boom...to bubble? , 2004, Nature Biotechnology.
[16] Suzanne S Farid,et al. A computer‐aided approach to compare the production economics of fed‐batch and perfusion culture under uncertainty , 2006, Biotechnology and bioengineering.
[17] John F. Kennedy,et al. Biochemical engineering and biotechnology handbook, 2nd edition: Edited by B. Atkinson and F. Mavituna, Macmillan Publishers, UK, 1991. xxix + 1271 pp. Price £75-00. ISBN 0-333-42403-1 , 1993 .
[18] Suzanne Farid. A decision-support tool for simulating the process and business perspectives of biopharmaceutical manufacture. , 2002 .
[19] Steve Griffith,et al. Uncertainty analysis of penicillin V production using Monte Carlo simulation. , 2005, Biotechnology and bioengineering.
[20] Suzanne S Farid,et al. Decision‐Support Tool for Assessing Biomanufacturing Strategies under Uncertainty: Stainless Steel versus Disposable Equipment for Clinical Trial Material Preparation , 2008, Biotechnology progress.
[21] Brian D Kelley. Bioprocessing of therapeutic proteins , 2001 .
[22] S Farid. A decision-support tool for simulating the process and business perspectives of biopharmaceutical manufacture [PhD Thesis]. University of London. , 2002 .
[23] Jochen Strube,et al. Challenges in biotechnology production—generic processes and process optimization for monoclonal antibodies , 2005 .
[24] Suzanne S. Farid,et al. Modelling of the biopharmaceutical drug development pathway and portfolio management , 2005, Comput. Chem. Eng..
[25] Suzanne S. Farid,et al. Retrofit Decisions within the Biopharmaceutical Industry: An EBA Case Study , 2006 .
[26] N J Titchener-Hooker,et al. Economic comparison between conventional and disposables-based technology for the production of biopharmaceuticals. , 2001, Biotechnology and bioengineering.
[27] Suzanne S Farid,et al. Established bioprocesses for producing antibodies as a basis for future planning. , 2006, Advances in biochemical engineering/biotechnology.
[28] Klaus D. Timmerhaus,et al. Plant design and economics for chemical engineers , 1958 .
[29] Suzanne S Farid,et al. Combining Multiple Quantitative and Qualitative Goals When Assessing Biomanufacturing Strategies under Uncertainty , 2008, Biotechnology progress.
[30] R. Werner,et al. Economic aspects of commercial manufacture of biopharmaceuticals. , 2004, Journal of biotechnology.
[31] T. Torphy,et al. Monoclonal antibodies: boundless potential, daunting challenges , 2002 .
[32] S. Wheelwright,et al. Restoring Our Competitive Edge: Competing Through Manufacturing , 1984 .
[33] S. Chamow,et al. Therapeutic antibody expression technology. , 2001, Current opinion in biotechnology.
[34] Yuhong Zhou,et al. Application of a Decision‐Support Tool to Assess Pooling Strategies in Perfusion Culture Processes under Uncertainty , 2008, Biotechnology progress.
[35] N. Afeyan,et al. Large–Scale Processing & High–Throughput Perfusion Chromatography , 1992, Bio/Technology.